Literature DB >> 8388126

Inactivation of the type II receptor reveals two receptor pathways for the diverse TGF-beta activities.

R H Chen1, R Ebner, R Derynck.   

Abstract

Transforming growth factor-beta (TGF-beta) is a multifunctional protein that regulates cell proliferation and differentiation and extracellular matrix production. Although two receptor types, the type I and type II receptors, have been implicated in TGF-beta-induced signaling, it is unclear how the many activities of TGF-beta are mediated through these receptors. With the use of cells overexpressing truncated type II receptors as dominant negative mutants to selectively block type II receptor signaling, the existence of two receptor pathways was shown. The type II receptors, possibly in conjunction with type I receptors, mediate the induction of growth inhibition and hypophosphorylation of the retinoblastoma gene product pRB. The type I receptors are responsible for effects on extracellular matrix, such as the induction of fibronectin and plasminogen activator inhibitor I, and for increased JunB expression. Selective inactivation of the type II receptors alters the TGF-beta response in a similar manner to the functional inactivation of pRB, suggesting a role for pRB in the type II, but not the type I, receptor pathway.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8388126     DOI: 10.1126/science.8388126

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  70 in total

Review 1.  Advances in gene therapy of liver cirrhosis: a review.

Authors:  W J Dai; H C Jiang
Journal:  World J Gastroenterol       Date:  2001-02       Impact factor: 5.742

Review 2.  TGF-beta signaling in mammary gland development and tumorigenesis.

Authors:  L M Wakefield; E Piek; E P Böttinger
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-01       Impact factor: 2.673

3.  Increased proteasome-dependent degradation of estrogen receptor-alpha by TGF-beta1 in breast cancer cell lines.

Authors:  Trevor A Petrel; Robert W Brueggemeier
Journal:  J Cell Biochem       Date:  2003-01-01       Impact factor: 4.429

4.  Type I (RI) and type II (RII) receptors for transforming growth factor-beta isoforms are expressed subsequent to transforming growth factor-beta ligands during excisional wound repair.

Authors:  L I Gold; J J Sung; J W Siebert; M T Longaker
Journal:  Am J Pathol       Date:  1997-01       Impact factor: 4.307

5.  TGF-beta promotes proliferation of cultured SMC via both PDGF-AA-dependent and PDGF-AA-independent mechanisms.

Authors:  G A Stouffer; G K Owens
Journal:  J Clin Invest       Date:  1994-05       Impact factor: 14.808

6.  Genetic screens to identify elements of the decapentaplegic signaling pathway in Drosophila.

Authors:  L A Raftery; V Twombly; K Wharton; W M Gelbart
Journal:  Genetics       Date:  1995-01       Impact factor: 4.562

7.  Characterization of a human hepatoma cell line with acquired resistance to growth inhibition by transforming growth factor beta 1 (TGF-beta 1).

Authors:  K Hasegawa; Z Wang; M Inagaki; B I Carr
Journal:  In Vitro Cell Dev Biol Anim       Date:  1995-01       Impact factor: 2.416

8.  Transforming growth factor-beta type-II receptor signalling: intrinsic/associated casein kinase activity, receptor interactions and functional effects of blocking antibodies.

Authors:  F L Hall; P D Benya; S R Padilla; D Carbonaro-Hall; R Williams; S Buckley; D Warburton
Journal:  Biochem J       Date:  1996-05-15       Impact factor: 3.857

9.  Bone morphogenetic protein 4 (BMP4) signaling in retinoblastoma cells.

Authors:  Maike Haubold; Andreas Weise; Harald Stephan; Nicole Dünker
Journal:  Int J Biol Sci       Date:  2010-11-24       Impact factor: 6.580

Review 10.  The multifunctional role of transforming growth factor (TGF)-beta s on mammary epithelial cell biology.

Authors:  C L Arteaga; T C Dugger; S D Hurd
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.